CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.
Also called NCT03056222
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 360 participants
- Sponsor
- I-Med-Pro GmbH
- Registry
-
NCT03056222
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Czechia, Germany, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03056222. Randomized; no masking; primary purpose treatment. Start 2017-04-10 (actual); primary completion 2021-08-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
- Acronym
- CF²
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Ablation catheter
- Lead sponsor
- I-Med-Pro GmbH
Record details
- Record id
cardio:ct-nct03056222- Content hash
247e135a9c537f43ec4d77531f9055c7704ab8b070dec6263662c3fa1cbc9ed5